Literature DB >> 14504690

Epigenetic properties of the diarrhetic marine toxin okadaic acid: inhibition of the gap junctional intercellular communication in a human intestine epithelial cell line.

Adama Traoré1, Isabelle Baudrimont, Sebastien Dano, Ambaliou Sanni, Yvan Larondelle, Yves Jacques Schneider, Edmond Ekue Creppy.   

Abstract

Okadaic acid (OA) is produced by several types of dinoflagellates (marine plankton) and has been implicated as the causative agent of diarrhetic shellfish syndrome. Previous studies have shown that okadaic acid is a tumor promoter and a specific potent inhibitor of protein phosphatases and protein synthesis. These effects in turn affect intracellular processes such as metabolism, contractility, gene transcription, and the maintenance of cytoskeletal structure. Gap junctional intercellular communication (GJIC) is a means of maintaining cellular homeostasis in organs, the disruption of which favors tumor cell growth. The GJIC involves the transfer of small water-soluble molecules through intercellular channels (gap junctions), composed of proteins called connexins. OA disrupts cellular homeostasis in Caco-2 cells through several mechanisms including protein synthesis inhibition, apoptosis, and clastogenic effects. The aim of this study was then to evaluate the expression of the connexin 43 (Cx 43) mRNA in relation with the cytotoxicity induced by OA (3.75-60 ng/ml) in a human colonic epithelial cell line in culture (Caco-2 cells). OA produced a dose-dependent inhibition of GJIC in Caco-2 cells, along with a parallel decrease in the expression of Cx 43 as shown by immunohistochemistry using anti-Cx 43 antibody. Since Cx 43 is implicated in the suppression of tumors and OA is a tumor promoter, the inhibition of GJIC may play an important role in its carcinogenesis. These data are discussed in relation to the toxicity of OA, total RNA synthesis, and possible specificity of Cx 43 inhibition in the GJIC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504690     DOI: 10.1007/s00204-003-0460-0

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  7 in total

1.  Comparative analysis of purified Pacific and Caribbean ciguatoxin congeners and related marine toxins using a modified ELISA technique.

Authors:  Cara E Campora; Y Hokama; Joanne S M Ebesu
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

Review 2.  Connexins and their channels in inflammation.

Authors:  Joost Willebrords; Sara Crespo Yanguas; Michaël Maes; Elke Decrock; Nan Wang; Luc Leybaert; Brenda R Kwak; Colin R Green; Bruno Cogliati; Mathieu Vinken
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-07-07       Impact factor: 8.250

3.  Identification of differentially expressed genes in SHSY5Y cells exposed to okadaic acid by suppression subtractive hybridization.

Authors:  Vanessa Valdiglesias; Juan Fernández-Tajes; Eduardo Pásaro; Josefina Méndez; Blanca Laffon
Journal:  BMC Genomics       Date:  2012-01-27       Impact factor: 3.969

4.  Comparative study of Domoic Acid and Okadaic Acid induced-chromosomal abnormalities in the Caco-2 cell line.

Authors:  Pinto-Silva Carvalho; R Catian; Serge Moukha; William G Matias; Edmond E Creppy
Journal:  Int J Environ Res Public Health       Date:  2006-03       Impact factor: 3.390

5.  Study of epigenetic properties of Poly(HexaMethylene Biguanide) hydrochloride (PHMB).

Authors:  Edmond E Creppy; Aboudoulatif Diallo; Serge Moukha; Christophe Eklu-Gadegbeku; Daniel Cros
Journal:  Int J Environ Res Public Health       Date:  2014-08-08       Impact factor: 3.390

6.  Long-term exposure to low levels of okadaic acid accelerates cell cycle progression in colonic epithelial cells via p53 and Jak/Stat3 signaling pathways.

Authors:  Lu Huang; Ji Gong; Yan Hu; Qiu-Lin Tan; Bo Liu; Xiao-Wen Yu; Xiang-Lin Hao; Qiao-Nan Guo
Journal:  Heliyon       Date:  2022-09-01

Review 7.  Inhibitors of connexin and pannexin channels as potential therapeutics.

Authors:  Joost Willebrords; Michaël Maes; Sara Crespo Yanguas; Mathieu Vinken
Journal:  Pharmacol Ther       Date:  2017-07-15       Impact factor: 12.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.